Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression

British Journal of Cancer

Volumn 88, Issue 5, 2003, Pages 718-725

  Colpaert, C G ^a   Vermeulen, P B ^a   Benoy, I ^b   Soubry, A ^c   Van Roy, F ^c   Van Beest, P ^a   Goovaerts, G ^b   Dirix, L Y ^b   Van Dam, P ^b   Fox, S B ^d   Harris, A L ^d   Van Marck, E A ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Angiogenesis Group   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; E cadherin; Fibrin; Hypoxia; Inflammatory breast cancer

Indexed keywords

CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; FIBRIN; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER GROWTH; CELL ADHESION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENDOTHELIUM CELL; GROWTH RATE; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CADHERINS; CARBONIC ANHYDRASES; CELL DIVISION; ENDOTHELIUM, VASCULAR; FIBRIN; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0037430060     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600807     Document Type: Article

References (40)

1. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Mushel RJ (2000) Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metasasis. Nat Med 6: 100-102
2. Alpaugh ML, Tomlinson JS, Kasraeian S, Barsky SH (2002) Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Oncogene 21: 3631-3643
3. Alpaugh ML, Tomlinson JS, Shao Z, Barsky SH (1999) A novel human xenograft of inflammatory breast cancer. Cancer Res 59: 5079-5084
4. Asgeirsson KS, Jonasson JG, Tryggvadottir L, Olafsdottir K, Sigurgeirsdottir JR, Ingvarsson S, Ogmundsdottir HM (2000) Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance. Eur J Cancer 36: 1098-1106
5. Aziz SA, Pervez S, Khan S, Kayani N, Azam SI, Rhabar MH (2001) Case control study of prognostic markers and disease outcome in inflammatory breast cancer: a unique clinical experience. Breast J 7: 398-404
6. Bonnier P, Charpin C, Lejeune C, Romain S, Tubiana N, Beedassy B, Martin PM, Serment H, Piana L (1995) Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition? Int J Cancer 62: 382-385
7. Chalkley HW (1943) Method for the quantitative morphologic analysis of tissues. J Natl Cancer Inst 4: 47-53
8. Chambler AFW, Drew PJ, Hill ADK, Darzi A, Monson JRT (1995) Inflammatory breast carcinoma. Surg Oncol 4: 245-254
9. Chevallier B, Asselain B, Kunlin A, Veyret C, Bastit P, Graic Y (1987) Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis. Cancer 60: 897-902
10. Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL (2001) Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19(16): 3660-3668
11. Colpaert C, Vermeulen P, Jeuris W, van Beest P, Goovaerts G, Weyler J, Van Dam P, Dirix L, Van Marck E (2001a) Early distant relapse in 'node-negative' breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol 193: 442-449
12. Colpaert C, Vermeulen P, van Beest P, Goovaerts G, Weyler J, Van Dam P, Dirix L, Van Marck E (2001b) Intratumoural hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph-node negative breast cancer patients. Histopathology 39: 416-425
13. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146(5): 1029-1039
14. Fields JN, Kuske RR, Perze CA, Fineberg BB, Bartlett N (1989) Prognostic factors in inflammatory breast cancer. Cancer 63: 1225-1232
15. Folkman J (1994) Angiogenesis and breast cancer. J Clin Oncol 12: 441-443
16. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene-transcription by hypoxia-inducible factor-1. Mol Cell Biol 16: 4604-4613
17. Harris AL (2002) Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47
18. Heimann R, Lan FS, McBride R, Hellman S (2000) Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res 60: 298-304
19. Jiang BH, Agani F, Passaniti A, Semenza GL (1997) V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57: 5328-5335
20. Jones JL, Royall JE, Walker RA (1996) E-cadherin relates to EFGR expression and lymph node metastasis in primary breast carcinoma. Br J Cancer 74: 1237-1241
21. Kleer CG, van Golen KL, Braun T, Merajver SD (2001) Persistent E-cadherin expression in inflammatory breast cancer. Mod Pathol 14(5): 458-464
22. Liotta L, Saidel G, Kleinerman J (1976) The significance of hematogenous tumor clumps in the metastatic process. Cancer Res 36: 889-894
23. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harvis AL, Stratford IJ, Hankinson O, Pugh CW, Radcliffe PJ (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94: 8104-8109
24. Moore DH, Rouse MB, Massenburg GS, Zeman EM (1992) Description of a spheroid model for the study of radiation and chemotherapy effects on hypoxic tumor cell populations. Gynecol Oncol 47: 44-47
25. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M (1993) Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701
26. Shirakawa K, Kobayashi H, Heike Y, Kawamoto S, Brechbiel MW, Kasumi F, Iwanaga T, Konishi F, Terada M, Wakasugi H et al (2002a) Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res 62: 560-566
27. Shirakawa K, Shibua M, Heike Y, Takashima S, Watanabe I, Konishi F, Kasumi F, Goldman C, Thomas K, Bett A, Terada M, Wakasugi H (2002b) Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. Int J Cancer 99: 344-351
28. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ (1996) Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 105: 394-402
29. Sugino T, Kusakabe T, Hoshi N, Yamaguchi T, Kawaguchi T, Goodison S, Sekimata M, Homma Y, Suzuki T (2002) An invasion-independent pathway of blood-borne metastasis. A new murine mammary tumor model. Am J Pathol 160: 1973-1980
30. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 25: 1451-1455
31. Tomlinson JS, Alpaugh ML, Barsky SH (2001) An intact overexpressed E-cadherin/α,β-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 61: 5231-5241
32. van Golen KL, Wu ZF, Qiao XT, Bao L, Merajver SD (2000a) RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 60: 5832-5838
33. van Golen KL, Wu ZF, Qiao XT Bao L, Merajver SD (2000b) RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia 2(5): 418-425
34. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Beliën JAM, de Waal RMW, Van Marck E, Magnani E, Weidner N, Harris AL, Dirix LY (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid tumours. Eur J Cancer 38: 1564-1579
35. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCullogh P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY (1996) Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474-2484
36. Vleminckx K, Vakaet Jr L, Mareel M, Fiers W, van Roy F (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppression role. Cell 66: 107-119
37. Weidner N (2002) New paradigm for vessel intravasation by tumor cells. Am J Pathol 160: 1937-1939
38. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
39. Wykoff CC, Beasley N, Watson PH, Campo L, Chia SK, English R, Pastorek J, Sly WS, Ratcliffe P, Harris AL (2001) Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 158(3): 1011-1019
40. Wykoff CC, Beasley N, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60: 7075-7083